The lipid-associated 3D structure of SPA, a broad-spectrum neuropeptide antagonist with anticancer properties

Biophysical Journal

Volumn 91, Issue 12, 2006, Pages 4478-4489

  Keire, David A ^a,b   Kumar, Mohanraja ^a,b   Hu, Weidong ^c   Sinnett Smith, James ^a,b   Rozengurt, Enrique ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DODECYL SULFATE SODIUM; GLUTAMINE; LYSINE; NEUROPEPTIDE; NEUROPEPTIDE ANTAGONIST; PHENYLALANINE; PROLINE; SUBSTANCE P; TRYPTOPHAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 33845404762     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.089292     Document Type: Article

References (51)

1. Ji, T. H., M. Grossmann, and I. Ji. 1998. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273:17299-17302.
2. Rozengurt, E. 2002. Neuropeptides as growth factors for normal and cancerous cells. Trends Endocrinol. Metab. 13:128-134.
3. Heasley, L. E. 2001. Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene. 20:1563-1569.
4. 11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells. Cancer Res. 57:51-54.
5. 8]-substance P(6-11) (antagonist G) induces AP-1 transcription and sensitizes cells to chemotherapy. Br. J. Cancer. 83:941-948.
6. Langdon, S., T. Sethi, A. Ritchie, M. Muir, J. Smyth, and E. Rozengurt. 1992. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. Cancer Res. 52:4554-4557.
7. 11]substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells. J. Biol. Chem. 271:29453-29460.
8. 11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res. 65:2738-2745.
9. 7,9]-SP by CD, NMR and MD simulations. Peptides. 26:875-885.
10. Inooka, H., T. Ohtaki, O. Kitahara, T. Ikegami, S. Endo, C. Kitada, K. Ogi, H. Onda, M. Fujino, and M. Shirakawa. 2001. Conformation of a peptide ligand bound to its G-protein coupled receptor. Nat. Struct. Biol. 8:161-165.
11. McDonnell, P. A., and S. J. Opella. 1993. Effect of detergent concentration on multidimensional solution NMR spectra of membrane proteins in micelles. J. Magn. Res. Series B. 102:120-125.
12. Kallick, D. H., M. R. Tessmer, C. R. Watts, and C. Y. Li. 1995. The use of dodecylphosphocholine micelles in solution NMR. J. Magn. Res. B. 109:60-65.
13. Schwyzer, R. 1995. 100 years lock-and-key concept: are peptides shaped and guided to their receptors by the target cell membrane. Biopolymers. 37:5-16.
14. Auge, S., B. Bersch, M. Tropis, and A. Milon. 2000. Characterization of substance P-membrane interaction by transferred nuclear Overhauser effect. Biopolymers. 54:297-306.
15. Keire, D. A., and T. G. Fletcher. 1996. The conformation of substance P in lipid environments. Biophys. J. 70:1716-1727.
16. Keire, D. A., and M. Kobayashi. 1998. The orientation and dynamics of substance P in lipid environments. Protein Sci. 7:2438-2450.
17. Wymore, T., and T. C. Wong. 1999. Molecular dynamics study of substance P peptides partitioned in a sodium dodecylsulfate micelle. Biophys. J. 76:1213-1227.
18. Whitehead, T. L., S. D. McNair, C. E. Hadden, J. K. Young, and R. P. Hicks. 1998. Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor. J. Med. Chem. 41:1497-1506.
19. Hong, S. Y., J. E. Oh, and K. H. Lee. 1999. Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem. Pharmacol. 58:1775-1780.
20. Rothemund, S., M. Beyermann, E. Krause, G. Krause, M. Bienert, R. S. Hodges, B. D. Sykes, and F. D. Sonnichsen. 1995. Structure effects of double D-amino acid replacements: a nuclear magnetic resonance and circular dichroism study using amphipathic model helices. Biochemistry. 34:12954-12962.
21. Braunschweiler, L., and R. R. Ernst. 1983. Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J. Magn. Res. 53:521-528.
22. Jeener, J., B. H. Meier, P. Bachmann, and R. R. Ernst. 1979. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Magn. Res. 71:4546-4554.
23. Sklenar, V. 1995. Suppression of radiation damping in multidimensional NMR experiments using magnetic field gradients. J. Magn. Res. A114:132-135.
24. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113:967-974.
25. States, D. J., R. A. Haberkorn, and D. J. Ruben. 1982. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Res. 48:286-292.
26. Piotto, M., V. Saudek, and V. Sklenar. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR. 2:661-665.
27. Hwang, T., and A. Shaka. 1995. Water suppression that works. excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Res. Series A. 112:275-279.
28. Brunger, A. T. 1992. X-PLOR: Version 3.1. A System for X-ray Crystallography and NMR. Yale Unviersity Press. New Haven, Conn.
29. Wuthrich, K., M. Billeter, and W. Braun. 1983. Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurement of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J. Mol. Biol. 169:949-961.
30. Perczel, A., and M. Hollosi. 1996. Turns. In Circular Dichroism and the Conformational Analysis of Biomolecules. G. Fasman, editor. Plenum Press, New York. 285-380.
31. Woody, R. W. 1994. Contributions of tryptophan side chains to the far-ultraviolet circular dichroism of proteins. Eur. Biophys. J. 23:253-262.
32. Ladokhin, A. S., M. E. Selsted, and S. H. White. 1999. CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix. Biochemistry. 38:12313-12319.
33. Ladokhin, A. S., S. Jayasinghe, and S. H. White. 2000. How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal. Biochem. 285:235-245.
34. 1H NMR and fluorescence spectroscopy. Biochemistry. 30:3387-3395.
35. de Kroon, A. I., M. W. Soekarjo, J. de Gier, and B. de Kruijff. 1990. The role of charge and hydrophobicity in peptide-lipid interaction: a comparative study based on tryptophan fluorescence measurements combined with the use of aqueous and hydrophobic quenchers. Biochemistry. 29:8229-8240.
36. Jacobs, R. E., and S. H. White. 1989. The nature of the hydrophobic binding of small peptides at the bilayer interface: implications for the insertion of transbilayer helicies. Biochemistry. 28:3421-3437.
37. de Planque, M. R., B. B. Bonev, J. A. Demmers, D. V. Greathouse, R. E. Koeppe 2nd, F. Separovic, A. Watts, and J. A. Killian. 2003. Interfacial anchor properties of tryptophan residues in transmembrane peptides can dominate over hydrophobic matching effects in peptidelipid interactions. Biochemistry. 42:5341-5348.
38. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR. 5:67-81.
39. Laskowski, R. A., J. A. Rullmannn, M. W. MacArthur, R. Kaptein, and J. M. Thornton. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8:477-486.
40. Moroder, L. 1997. On the mechanism of hormone recognition and binding by the CCK-B/gastrin receptor. J. Pept. Sci. 3:1-14.
41. Moroder, L., R. Romano, W. Guba, D. F. Mierke, H. Kessler, C. Delporte, J. Winand, and J. Christophe. 1993. New evidence for a membrane-bound pathway in hormone receptor binding. Biochemistry. 32:13551-13559.
42. Giragossian, C., and D. F. Mierke. 2002. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor. Biochemistry. 41:4560-4566.
43. Perkins, S. J., and K. Wuthrich. 1979. Ring current effects in the conformation dependent NMR chemical shifts of aliphatic protons in the basic pancreatic trypsin inhibitor. Biochim. Biophys. Acta. 576:409-423.
44. 8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. Br. J. Cancer. 80:1026-1034.
45. Seckl, M. J., R. H. Newman, P. S. Freemont, and E. Rozengurt. 1995. Substance P-related antagonists inhibit vasopressin and bombesin but not 5′-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells. J. Cell. Physiol. 163:87-95.
46. 12 in Swiss 3T3 cells. J. Biol. Chem. 275:30644-30652.
47. Janecka, A., J. Poels, J. Fichna, K. Studzian, and J. Vanden Broeck. 2005. Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay. Regul. Pept. 131:23-28.
48. Jensen, R. T., D. H. Coy, Z. A. Saeed, P. Heinz-Erian, S. Mantey, and J. D. Gardner. 1988. Interaction of bombesin and related peptides with receptors on pancreatic acinar cells. Ann. N. Y. Acad. Sci. 547:138-149.
49. Yachnis, A. T., J. N. Crawley, R. T. Jensen, M. M. McGrane, and T. W. Moody. 1984. The antagonism of bombesin in the CNS by substance P analogues. Life Sci. 35:1963-1969.
50. Di Bello, C., A. Scatturin, G. D'Auria, M. Gargiulo, L. Paolillo, E. Trivellone, and R. De Castiglione. 1991. Fluorescence, CD, and NMR studies on spantide, a bombesin and substance P antagonist. Biopolymers. 31:643-652.
51. Wishart, D. S., B. D. Sykes, and F. M. Richards. 1992. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry. 31:1647-1651.